EFFECTS OF SPIRONOLACTONE IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK IN TOPCAT AMERICAS

被引：0
|
作者：
Chatur, Safia [1 ]
Beldhuis, Iris [1 ]
Neuen, Brendon [1 ]
Claggett, Brian [1 ]
Desai, Akshay S. [1 ]
Lewis, Eldrin F. [1 ]
Anand, Inderjit S. [1 ]
Shah, Sanjiv Jayendra [1 ]
Sweitzer, Nancy K. [1 ]
Fang, James C. [1 ]
Pitt, Bertram [1 ]
Pfeffer, Marc A. [1 ]
Vaduganathan, Muthiah [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1051-07
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF SPIRONOLACTONE ON MYOCARDIAL HYPERECITABILITY OF PATIENTS IN HEART-FAILURE
    TOURNIAIRE, A
    BLUM, J
    COEUR ET MEDECINE INTERNE, 1973, 12 (01): : 147 - 152
  • [22] Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure
    Chatur, Saba
    Neuen, Brendon L.
    Claggett, Brian L.
    Beldhuis, Iris E.
    Causland, Finnian R. Mc
    Desai, Akshay S.
    Rouleau, Jean L.
    Zile, Michael R.
    Lefkowitz, Martin P.
    Packer, Milton
    McMurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (22) : 2148 - 2159
  • [23] Spironolactone use in patients with heart failure
    Trujillo, JM
    Gonyeau, MJ
    DiVall, MV
    Alexander, SL
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (02) : 165 - 170
  • [24] Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart Failure
    Secora, Alex M.
    Shin, Jung-Im
    Qiao, Yao
    Alexander, G. Caleb
    Chang, Alex R.
    Inker, Leslie A.
    Coresh, Josef
    Grams, Morgan E.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (11) : 2408 - 2419
  • [25] Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney disease
    Buckallew, Amanda R.
    Tellor, Katie B.
    Watson, Rachel
    Miller, William
    Mbachu, Gina
    Whitlock, Cameron
    Seltzer, Jay R.
    Armbruster, Anastasia L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (07) : 955 - 960
  • [26] Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney disease
    Amanda R. Buckallew
    Katie B. Tellor
    Rachel Watson
    William Miller
    Gina Mbachu
    Cameron Whitlock
    Jay R. Seltzer
    Anastasia L. Armbruster
    European Journal of Clinical Pharmacology, 2021, 77 : 955 - 960
  • [27] Hyperkalemia risk with spironolactone in patients with heart failure using loop diuretics
    Secora, Alex
    Shin, Jung-Im
    Qiao, Yao
    Alexander, G. Caleb
    Coresh, Josef
    Grams, Morgan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 569 - 570
  • [28] Empagliflozin in Patients With Heart Failure Efficacy and Safety Concerns Across Kidney Risk Categories
    Ohshiro, Yuzuru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (15) : E133 - E133
  • [29] Older patients with heart failure are at higher risk of hyperkalemia with spironolactone: results from a heart failure programme
    Belziti, C.
    Vensentini, N.
    Vulcano, N.
    Fernandez, S.
    De Arenaza, D. Perez
    CIRCULATION, 2008, 118 (12) : E328 - E328
  • [30] Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
    Selvaraj, Senthil
    Claggett, Brain
    Shah, Sanjiv
    Anand, Inder
    Rouleau, Jean
    O'Meara, Eileen
    Desai, Akshay
    Lewis, Eldrin
    Pitt, Bertram
    Sweitzer, Nancy
    Fang, James
    Solomon, Scott
    CIRCULATION, 2018, 138
12345